viewAnteris Technologies Ltd

Admedus Ltd outlines board changes


Specialist healthcare company Admedus Ltd (ASX:AHZ), has announced that Lee Rodne has resigned as managing director and chief executive officer of the company, effective 30th June 2016.

Wayne Paterson, chairman, commented: “The board thanks Mr. Rodne for his leadership and guidance of the company over the past 10 years and we wish him well in his future endeavours.

“We have an experienced senior management team and board who will work with me to manage the business until the nominations committee selects our new managing director.”

Paterson will act as interim managing director.

Admedus remains focused on investing in and developing next generation technologies with world class partners, acquiring strategic assets to grow product and service offerings and expanding revenues.

The company has assets from research & development through clinical development as well as sales, marketing and distribution.


Proactive Investors Australia is the market leader in producing news, articles and research reports on ASX emerging companies with distribution in Australia, UK, North America and Hong Kong / China.

Quick facts: Anteris Technologies Ltd

Price: 3.67 AUD

Market: ASX
Market Cap: $21.69 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Anteris Technologies Ltd named herein, including the promotion by the Company of Anteris Technologies Ltd in any Content on the Site, the...


Admedus CEO in New York to update on recent key milestones

Admedus Ltd (ASX:AHZ) CEO Wayne Paterson visited the Proactive Investors New York studio to update on key milestones the company has achieved in the past few months, including receiving European approval on two of its products.

on 03/17/2019

2 min read